Overview

Clinical Equivalence of Two Generic Butenafine Hydrochloride 1% Creams as Compared to Lotrimin Ultra Cream in Patients With Interdigital Tinea Pedis

Status:
Terminated

Trial end date:
2011-07-01

Target enrollment:

Participant gender:

Summary

To demonstrate comparable safety and efficacy of Taro Pharmaceuticals, Inc butenafine hydrochloride cream 1% test product and Lotrimin Ultra cream (reference listed drug) in the treatment of interdigital tinea pedis, and to show the superiority of the active treatments over that of the placebo (vehicle).

Phase:

Phase 1

Details

Lead Sponsor:

Taro Pharmaceuticals USA

Treatments:

Butenafine
Clotrimazole
Miconazole